Company Sernova Corp. Toronto S.E.
Equities
SVA
CA81732W1041
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 CAD | +2.33% | -7.53% | -38.57% |
Apr. 02 | Sernova Corp. Provides Positive Clinical and Platform Portfolio Update | CI |
Mar. 19 | Sernova Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Cynthia Pussinen
CEO | Chief Executive Officer | - | 23-09-04 |
Delfina Siroen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Frank Shannon
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-29 |
Philip Toleikis
CTO | Chief Tech/Sci/R&D Officer | - | 09-04-27 |
Investor Relations Contact | - | - | |
Modestus Obochi
PRN | Corporate Officer/Principal | - | 23-09-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Parsons
BRD | Director/Board Member | 58 | 12-04-18 |
Philip Toleikis
CTO | Chief Tech/Sci/R&D Officer | - | 09-04-27 |
Daniel Mahony
BRD | Director/Board Member | - | 22-09-29 |
Brett Whalen
CHM | Chairman | - | 23-04-26 |
Steven Sangha
BRD | Director/Board Member | - | 23-04-23 |
Cynthia Pussinen
CEO | Chief Executive Officer | - | 23-09-04 |
Director/Board Member | - | 23-04-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 303,407,686 | 264,855,343 ( 87.29 %) | 0 | 87.29 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.38% | 128B | |
-10.58% | 10.66B | |
-0.39% | 8.55B | |
+12.78% | 7.1B | |
+24.12% | 5.06B | |
+7.07% | 3.4B | |
-1.77% | 3.08B | |
-11.96% | 2.11B | |
-7.25% | 2.03B |
- Stock Market
- Equities
- SVA Stock
- SVA Stock
- Company Sernova Corp.